Wikipedia -WSS

Wikipedia

author：fashion 2025-10-01 22:59:15 - browse：11457

Colorful broken DNA helix genome. -- health coverage from STAT — Adobe

In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases.

The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.

Last week, the grand plan took perhaps a final blow. Taysha announced it would discontinue development of a treatment for giant axonal neuropathy, or GAN, a fatal, degenerative disease known to affect fewer than 100 people worldwide. The FDA, Taysha said, had requested an additional clinical trial that would be infeasible.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： An innovative path out of biotech’s “valley of death”

leisure time

explore

WSS

Large hospital system sues Multiplan for low

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Bispecific antibodies are next new thing in cancer immunotherapy

Newly revealed memo details efforts to keep Trump in power following election loss

The history of OxyContin, told through Purdue Pharma documents

White House drug shortages task force keeps mum with Congress

entertainment

Wikipedia

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Can medical device makers keep up in the race to treat obesity?

Drug repurposing or repositioning? The language matters

Mom launches Girl Scout troop for LGBTQ youth in Texas

Sports medicine is finally prioritizing gender equality

The perfect storm of weather conditions that led to the devastating wildfires in Maui

New air purifier tech could be key to improving indoor air quality

Living organ donors deserve priority status for transplants

Cancer drug shortages should be causing more outrage

After John Oliver segment, STAT readers share their opioid

entertainment

An innovative path out of biotech’s “valley of death”

The thinking behind the controversial eating disorder chatbot Tessa

Living organ donors deserve priority status for transplants

Xenotransplantation trials will require adjusting expectations, experts say

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

After John Oliver segment, STAT readers share their opioid

leisure time

explore

explore

leisure time